We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$718B
AUM Growth
+$49.7B
Cap. Flow
-$15.6B
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.75%
Holding
3,044
New
123
Increased
1,636
Reduced
968
Closed
150

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.11B
2
META icon
Meta Platforms (Facebook)
META
+$2.59B
3
EQT icon
EQT Corp
EQT
+$1.31B
4
CL icon
Colgate-Palmolive
CL
+$1.08B
5
ADBE icon
Adobe
ADBE
+$1.06B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.92B
2
UNH icon
UnitedHealth
UNH
+$1.78B
3
AMD icon
Advanced Micro Devices
AMD
+$1.55B
4
ROST icon
Ross Stores
ROST
+$1.54B
5
ASML icon
ASML
ASML
+$1.49B

Sector Composition

Rank Sector Weight
1 Technology 31.61%
2 Healthcare 16.91%
3 Consumer Discretionary 11.05%
4 Financials 10.6%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZLAB icon
601
Zai Lab
ZLAB
$2.92B
$72.8M 0.01%
2,625,115
+215,742
+9% +$7.06M
ALB icon
602
Albemarle
ALB
$15.4B
$72.2M 0.01%
323,743
+83,718
+35% +$17.1M
DOCS icon
603
Doximity
DOCS
$4.69B
$71.8M 0.01%
2,111,194
-241,542
-10% -$8.04M
FN icon
604
Fabrinet
FN
$20.3B
$71.1M 0.01%
547,407
+38,766
+8% +$4.14M
AWK icon
605
American Water Works
AWK
$27.1B
$71M 0.01%
497,266
-678
-0.1% -$99.6K
AMN icon
606
AMN Healthcare
AMN
$1.32B
$70.7M 0.01%
647,487
-1,264
-0.2% -$120K
NXST icon
607
Nexstar Media Group
NXST
$5.81B
$70.6M 0.01%
423,623
+16,033
+4% +$2.66M
RPRX icon
608
Royalty Pharma
RPRX
$26B
$70.5M 0.01%
2,294,416
-181,531
-7% -$6.15M
B
609
Barrick Mining
B
$67.4B
$70.5M 0.01%
4,161,888
+1,295,716
+45% +$23.6M
PLNT icon
610
Planet Fitness
PLNT
$3.7B
$70.2M 0.01%
1,040,322
+222,933
+27% +$16M
SGRY icon
611
Surgery Partners
SGRY
$1.96B
$70M 0.01%
1,555,043
+620,680
+66% +$23.7M
PFGC icon
612
Performance Food Group
PFGC
$16.3B
$69.9M 0.01%
1,160,603
-361,791
-24% -$21.3M
BYD icon
613
Boyd Gaming
BYD
$6.01B
$69.5M 0.01%
1,001,744
-2,781
-0.3% -$187K
PPG icon
614
PPG Industries
PPG
$25.5B
$69.5M 0.01%
468,567
-6,548
-1% -$914K
CTVA icon
615
Corteva
CTVA
$50.2B
$68.9M 0.01%
1,202,164
-52,910
-4% -$3.09M
PH icon
616
Parker-Hannifin
PH
$133B
$68.6M 0.01%
175,969
-347
-0.2% -$117K
DPZ icon
617
Domino's
DPZ
$11.7B
$68.5M 0.01%
203,312
+36,574
+22% +$11.5M
MMSI icon
618
Merit Medical Systems
MMSI
$5.43B
$68.1M 0.01%
814,590
+7,104
+0.9% +$578K
MSGE icon
619
Madison Square Garden
MSGE
$4B
$68M 0.01%
+2,023,194
New +$69.4M
ONTO icon
620
Onto Innovation
ONTO
$20.6B
$68M 0.01%
583,893
+58,858
+11% +$5.62M
AGL icon
621
Agilon Health
AGL
$1.53B
$67.5M 0.01%
155,668
+63,508
+69% +$35.7M
XEL icon
622
Xcel Energy
XEL
$49.4B
$67M 0.01%
1,077,610
-92,213
-8% -$6.16M
IPG
623
DELISTED
Interpublic Group of Companies
IPG
$66.9M 0.01%
1,733,339
-4,073
-0.2% -$154K
ARVN icon
624
Arvinas
ARVN
$586M
$66.9M 0.01%
2,694,036
+180,318
+7% +$4.64M
EXLS icon
625
EXL Service
EXLS
$5.36B
$66.4M 0.01%
2,198,305
-20,970
-0.9% -$661K

Similar funds

T. Rowe Price Associates's Q2 2023 Portfolio in Review

As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
  • T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
  • T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
  • T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
  • T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
  • T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.